Investors / China / Legend Capital
Legend Capital
Venture capital · Beijing, China · Asia Pacific
Legend Capital is a Chinese private equity and venture capital investment institution founded in April 2001. It focuses on early-stage venture investment and growth-stage private equity investment, and has invested in over 700 companies with total assets under management exceeding RMB 90 billion.
Invests inHealthcare & BiotechRobotics & HardwareMobility & Logistics
In its own wordstechnology innovationearly stagegrowth stageprivate equityventure capital
Your fit with Legend Capital
Three questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsLegend Capital has 11 checked portfolio companies on record and is named in 16 funding rounds, 4 of them as lead. Its most frequent entry is Seed, 75% of the 4 companies where the round it came in at is known. Its largest themes are Healthcare & Biotech (55%), Robotics & Hardware (18%) and Mobility & Logistics (18%). 70% of its 10 companies with a known country are based in China. It shares the most portfolio companies with IDG Capital, 5Y Capital and Ascenta Capital.
Counts come from funding rounds that name Legend Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Reports often leave out co-leads, so a firm may have led more rounds than shown. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage it came in at · n=4Counted only where the round is where it came in: a pre-seed or seed round, or a later round after the company raised without it.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 75% |
| Series A | 0% |
| Series B | 0% |
| Growth | 25% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 2 | 0 |
| '25 | 4 | 1 |
| '26 | 10 | 3 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 24th | 11 companies |
| Recent activity | 96th | 12 rounds in 12 months |
| Early stage | 23rd | 75% of 4 known entries at pre-seed or seed |
| Evidence | 24th | 0% of companies confirmed by a round |
| Sector focus | 72nd | 55% of companies in its largest theme |
| Reach | 52nd | 3 countries, from 10 companies with a known country |
Shares portfolio companies with
firms that back the same companies, not always in the same roundShow as a table
| Share | |
|---|---|
| IDG Capital | 2 |
| 5Y Capital | 1 |
| Ascenta Capital | 1 |
| B Capital | 1 |
| Forbion | 1 |
| Frazier Life Sciences | 1 |
| Future Capital Discovery Fund | 1 |
| Glory Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers11100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its 11 companies with a theme; a company can have twoThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 55% | 17% |
| Robotics & Hardware | 18% | 4% |
| Mobility & Logistics | 18% | 4% |
| AI & Machine Learning | 9% | 13% |
| Developer Tools | 9% | 5% |
| Semiconductors & Electronics | 9% | 2% |
| Fintech | 9% | 9% |
Shared portfolio network
firms that back the same companies, and what they share with each otherCompare Legend Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Legend Capital| Date | Company | Stage |
|---|---|---|
| 3 Nov 2026 | Series C+ | |
| 22 Oct 2026 | Series C+ | |
| 3 Sept 2026 | Series B | |
| 12 Aug 2026 | Series A Led | |
| 1 Jul 2026 | Seed Led | |
| 29 Apr 2026 | Series C+ | |
| 8 Apr 2026 | Series A | |
| 8 Jan 2026 | Seed |
Round details for Legend Capital
Amounts, full round histories and every co-investor in Legend Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
11 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Allink Biotherapeutics focuses on the early discovery, clinical development, and commercialization of dual antibodies and dual antibody ADCs. | Healthcare & Biotech | Nov 2024Series A · 2 rounds | Funding round | |
| Angitia Biopharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases. | Healthcare & Biotech | Dec 2024Series C+ | Funding round | |
| Beyang Therapeutics is an innovative biopharmaceutical company that employs its proprietary ExCEED platforms to accelerate the process of new drug discovery and development in disease areas of significant unmet medical needs. | Healthcare & Biotech | Aug 2026Series A | Funding round | |
| The company develops and provides an application and API for web search and data scraping. | AI & Machine LearningDeveloper Tools | Oct 2026Series C+ | Funding round | |
| The company develops and sells robotic platforms and solutions, including mechanical arms and mobile platforms, for various applications such as research, education, and data collection. | Robotics & Hardware | Jul 2026Seed | Funding round | |
| Nanochap Electronics Co., Ltd develops and manufactures brain-computer interfaces and biochips, including products for restoring vision and neural stimulation. | Semiconductors & ElectronicsHealthcare & Biotech | Nov 2026Series C+ | Funding round | |
| The company develops and manufactures autonomous vehicles for logistics and transportation. | Mobility & LogisticsRobotics & Hardware | Oct 2025Series C+ | Funding round | |
| NeuShen Therapeutics is a global biotech company dedicated to pioneering novel therapies for psychiatric and neurological disorders that impact millions of people worldwide. | Healthcare & Biotech | Sept 2026Series B | Funding round | |
| Obita provides a payment infrastructure for enterprises to make and receive payments across borders | Fintech | Sept 2025Seed · 2 rounds | Funding round | |
| Volant develops and manufactures electric vertical take-off and landing aircraft for commercial passenger transport and other applications | Mobility & Logistics | Apr 2026Series C+ | Funding round | |
| Xellar Biosystems develops and provides an organ-on-chip platform for predictive drug discovery | Healthcare & Biotech | Apr 2026Series A | Funding round |
About this data
site last read 13 Nov 2026- Site
- legendcapital.com.cn
- Last read
- 13 Nov 2026
- Watching since
- 16 Nov 2026
- Rounds since
- 28 Nov 2024
- Companies checked
- 11
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Legend Capital's profile as data
Pull Legend Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/legendcapital.com.cn
# also
GET /v1/firms/legendcapital.com.cn/portfolio
GET /v1/firms/legendcapital.com.cn/coinvestors
GET /v1/firms/legendcapital.com.cn/news